A photographic illustration that represents the edition of genes. Using its new progen3 AI model, the Profluent biotechnology startup has developed new gene editing proteins that can be more effective than CRISPR-CAS9 systems that support most of contemporary gene edition therapies.
Photographic Illustration – Getty Images
